Nomura Holdings Inc Amgen Inc Call Options Transaction History

Nomura Holdings Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $13.1 Million - $14.2 Million	42,200 New	42,200 $13.6 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $33.9 Million - $41.3 Million	150,000 New	150,000 $36.3 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $6.84 Million - $7.71 Million	-37,800 Reduced 79.92%	9,500 $1.8 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $2.93 Million - $3.43 Million	17,300 Added 57.67%	47,300 $8.09 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $5.02 Million - $5.73 Million	30,000	30,000 $5.53 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.